49.
[1]. Guinamard R, et al. Flufenamic acid as an ion channel modulator. Pharmacol Ther. 01 May;18():7-84.
[]. Pobbati AV, et al. Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy. Structure. 015;(11):076-086.
[]. Pongkorpsakol P, et al. Cellular mechanisms underlying the inhibitory effect of flufenamic acid on chloride secretion in human intestinal epithelial cells. J Pharmacol Sci. 017 Jun;14():9-100.
[4]. Pongkorpsakol P, et al. Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation. Eur J Pharmacol. 017 Mar 5;798:94-104.
[5]. Alfonso Pérez-Garrido, et al. Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins. Bioorg Med Chem. 009 Jan 15;17():896-904.
H01-H15-H19
P64-P70-P80-P0+P5-P0-P6+P64-P405-P501
811
![]()
![]()